|
[Related PubMed/MEDLINE]
Total Number of Papers: 27
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer. |
high-TB, TKI |
| 2 |
2021 |
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. |
MM, NRM, REL |
| 3 |
2021 |
Nomograms including the controlling nutritional status score in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation for prediction survival: a retrospective analysis. |
CONUT, HCC, TACE |
| 4 |
2021 |
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement. |
FET |
| 5 |
2020 |
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer. |
mCRC |
| 6 |
2020 |
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET. |
AA, FET, GBM, IDH, MGMT, MTV, TTP, WHO |
| 7 |
2020 |
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer. |
BL, MBC, sTK1, TK1 |
| 8 |
2019 |
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma. |
GBM, MRI |
| 9 |
2019 |
Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy. |
EMT, ICB, NSCLC |
| 10 |
2019 |
Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease? |
EOC, IP |
| 11 |
2018 |
The role novel targeted agents in the treatment of previously treated patients with advanced urothelial carcinoma (UC): a meta-analysis. |
DCR, ICIs, ORR, TAs, TKIs, UC |
| 12 |
2018 |
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care. |
HR-MDS, TFIs |
| 13 |
2016 |
A decrease in D-dimer concentration and an occurrence of skin rash as iatrogenic events and complementary predictors of survival in lung cancer patients treated with EGFR tyrosine kinase inhibitors. |
NSCLC, TKIs |
| 14 |
2016 |
Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis. |
DCR, ORR, RR, UC |
| 15 |
2015 |
Prognostic potential of initial CT changes for progression-free survival in gefitinib-treated patients with advanced adenocarcinoma of the lung: a preliminary analysis. |
CT, EGFR, NRC, NSCLC |
| 16 |
2014 |
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results. |
mCRC |
| 17 |
2014 |
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review. |
LFFR, RR, SCCHN |
| 18 |
2014 |
Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab. |
CET, DCE-MRI, rGB, VWR |
| 19 |
2014 |
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma. |
HGSOC, IPA, URA |
| 20 |
2014 |
Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases. |
SBT |
| 21 |
2014 |
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis. |
RCC |
| 22 |
2012 |
A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer. |
CCI, NSCLC, PDGFR, RR, VES-13 |
| 23 |
2012 |
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). |
CML, pts, TKI |
| 24 |
2012 |
Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome. |
F-BSG, SBT, WHO |
| 25 |
2010 |
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome. |
ES, HSCT, NRM |
| 26 |
2009 |
Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate. |
GIST, GP, IM, LP, RD, SU |
| 27 |
2004 |
Epidemiology, clinical features and treatment outcome of Wilms' tumor in Taiwan: a report from Taiwan Pediatric Oncology Group. |
TPOG, WT |
|
A Search Service for Abbreviation / Long Form
